Skip to main content

TLSI

Stock
Health Care
Medical Devices

Performance overview

TLSI Price
Price Chart

Forward-looking statistics

Beta
0.14
Risk
66.94%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Company info

SectorHealth Care
IndustryMedical Devices
Employees—
Market cap$176.8M

Fundamentals

Enterprise value$226.3M
Revenue$32.1M
Revenue per employee—
Profit margin-84.67%
Debt to equity-0.96

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$1.10
Dividend per share—
Revenue per share$1.21
Avg trading volume (30 day)$470K
Avg trading volume (10 day)$1M
Put-call ratio—

Macro factor sensitivity

Growth-14.7
Credit+4.3
Liquidity-20.2
Inflation+0.3
Commodities-4.8
Interest Rates-5.9

Valuation

Dividend yield0.00%
PEG Ratio-4.30
Price to sales5.99
P/E Ratio-4.30
Enterprise Value to Revenue7.04
Price to book-4.05

Upcoming events

Next earnings dayMarch 27, 2025
Next dividend day—
Ex. dividend day—

News

TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates

TriSalus Life Sciences, Inc. (TLSI) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.54 per share a year ago.

Zacks Investment Research (May 15, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free